Adapting to post-COVID19 research in Parkinson's disease: Lessons from a multinational experience

• Authors: Eng-King Tan, National Neuroscience Institute; Alberto Albanese, IRCCS Humanitas Research Hospital; KRay Chaudhuri, Kings College London; Shen-Yang Lim, Universiti Malaya; Nicodemus Oey, National Neuroscience Institute; Christine Hui Shan Chan, National Neuroscience Institute; Yun-Cheng Wu, Shanghai Jiao Tong University; Beomseok Jeon, Seoul National University Hospital; Daniel Truong, University of California Los Angeles; Werner Poewe, Medical University of Innsbruck; Pramod Kumar Pal, National Neuroscience Institute of Mental Health and Neurosciences; Louis Tan, National Neuroscience Institute; Puneet Opal, Northwestern University; Carlo Colosimo, Azienda Ospedaliera Santa Maria; Hyder Jinnah, Emory University; Francisco Cardoso, Federal University of Minas Gerais
• Journal Title: Parkinsonism & Related Disorders
• Volume: Volume 82
• Publisher: Elsevier Science Ltd. | 2021-01-07, Pages 146-149
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.1016/j.parkreldis.2020.10.009
• Subjects: Biology, Neuroscience; Health Sciences, Epidemiology; Health Sciences, Medicine and Surgery
• Keywords: Science & Technology; Life Sciences & Biomedicine; Clinical Neurology; Neurosciences & Neurology; COVID-19; Clinical research; Parkinson's disease trials; Country-specific challenges

Abstract

With more than 30 million confirmed cases and almost a million deaths, COVID-19 is redefining the way clinical research is being conducted around the world. Lifting of lockdown measures when community spread appeared to have abated has led to resurgence of new clusters, resulting in prompt reinstitution of restrictions such as that experienced in Korea, China, Italy, India, and certain cities in Brazil and the USA. This dynamic back and forth curtailment will likely go on until an effective treatment or vaccine is widely available, necessitating novel adaptations for researchers to continue to thrive worldwide.